NLM Technical Bulletin, Mar-Apr 2022, History of Medicine Finding Aids Consortium to Retire on April 15, 2022
On April 15, 2022, the National Library of Medicine (NLM) History of Medicine (HMD) Finding Aids Consortium (https://www.nlm.nih.gov/hmd/consortium/index.html) will be retired due to declining use and the technology advancements of other common web indexing services.
Source: NLM Technical Bulletin - March 29, 2022 Category: Databases & Libraries Source Type: news

Corns, Calluses and Properly Fitting Children ’ s Shoes
Discussion Probably the most common foot problem is foot pain or skin problems. This can be due to chronic and acute trauma, mobility issues, normal development, activities and footwear. Common foot problems include: Acute trauma is probably one of the most common reason patients and families seek care for is pain after acute trauma. Children prior to full puberty with acute trauma may have a growth plate fractures or Salter-Harris fractures which can be reviewed here. Apophysitis and tendonitis are common overuse injuries where there is irritation of the tendon and its insertion points. Chronic overuse can also lead to f...
Source: PediatricEducation.org - March 28, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Dalton Schultz getting franchise tag from Cowboys
Add another tight end to the list of players getting franchise tags this year.Ian Rapoport of NFL Media reports that the Cowboys are using their tag on Dalton Schultz. He joins Mike Gesicki of the... #cowboys #davidnjoku #mikegesicki #browns #daltonschultz #ianrapoport #nflmedia
Source: Reuters: Health - March 8, 2022 Category: Consumer Health News Source Type: news

2022 NFL franchise tag tracker -- Kansas City Chiefs' Orlando Brown Jr. first to be tagged
Before free agency kicks off for the 2022 NFL offseason, teams are allowed to apply franchise tags to players to give them a sense of what they need to do before the league year starts on March... #kansascitychiefs #freeagency #orlandobrownjr #franchisetagtracker #adamschefter
Source: Reuters: Health - March 7, 2022 Category: Consumer Health News Source Type: news

MMQB: How Aidan Hutchinson Became a Top Draft Prospect
The Michigan pass rusher talks about his diet, his play and reaching out to TB12. Plus, why the combine is at a crossroads, and notes on Aaron Rodgers, Kyler Murray, franchise tags and more. #aidanhutchinson #crossroads #rushertalks #kylermurray #aaronrodgers
Source: Reuters: Health - March 7, 2022 Category: Consumer Health News Source Type: news

U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

These Classes Are Near-Death Experiences, and That ’s a Good Thing
Spirits are high as the students file into the basement of the Galante Funeral Home in Union, N.J., to pick out their caskets. Jessica Polynice, 23, beelines toward the most ornate one in the showroom, joking that she has expensive taste. Others consider the prominently displayed price tags, from $995 to nearly $6,000, and factor in the softness of the pillows. Surrounded by open caskets, Amanda Davis, 20, says she’d rather be cremated into a firework. Beside her, Lauren Duffy, 24, flips through a brochure for artificial reef cremations and weighs whether she’d like to be eternally memorialized on the ocean flo...
Source: TIME: Health - February 23, 2022 Category: Consumer Health News Authors: Melissa Chan Tags: Uncategorized COVID-19 feature nationpod Source Type: news

COVID-19 Response: Living with COVID-19, Cabinet Office (updated 23rd February 2022)
This document outlines the government ' s plan for living with COVID-19, which - underpinned by vaccines - will remove the remaining legal domestic restrictions while continuing to protect people most vulnerable to COVID-19 and maintaining resilience. 23 February 2022Added HTML version of ' COVID-19 Response: Living with COVID-19 ' . 21 February 2022First published.
Source: Current Awareness Service for Health (CASH) - February 23, 2022 Category: Consumer Health News Source Type: news

Scientific evidence supporting the government response to coronavirus (COVID-19), SAGE (updated 18th February 2022)
Evidence considered by the Scientific Advisory Group for Emergencies (SAGE). 18 February 2022We ' ve added 10 new papers to February 2022 and added an HTML version of one paper. We ' ve also corrected the author attribution of a paper from April 2020. 11 February 2022Added link to February 2022 SAGE document collection.
Source: Current Awareness Service for Health (CASH) - February 18, 2022 Category: Consumer Health News Source Type: news

Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the Phase 3 MAGNITUDE study evaluating the investigational use of niraparib, a selective poly-ADP ribose polymerase (PARP) inhibitor, in combination with abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) with or without specific homologous recombination repair (HRR) gene alterations. At the final analysis for radiographic progression-free survival (rPFS), the treatment combination of niraparib and abiraterone acetate plus prednisone de...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Here ’s How to Save Wordle in Its Pure, Pre-NYT Form
Users can save Wordle as an HTML file and play the game offline for over 2,000 days. #savewordle
Source: Reuters: Health - February 1, 2022 Category: Consumer Health News Source Type: news

COVID-19 vaccination: British Sign Language resources, UKHSA (updated 19th January 2022)
British Sign Language (BSL) videos on COVID-19 vaccination. 19 January 2022Updated BSL video of the COVID-19 vaccination guide for children and young people or parents. 9 November 2021Updated HTML pages and added new links.
Source: Current Awareness Service for Health (CASH) - January 20, 2022 Category: Consumer Health News Source Type: news

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of ...
Source: Johnson and Johnson - January 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant
NEW BRUNSWICK, N.J., December 30, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a homologous (same vaccine) booster shot of the Johnson & Johnson COVID-19 vaccine (Ad26.COV2.S) demonstrated 85 percent effectiveness against COVID-19-related hospitalization. The study, conducted by the South African Medical Research Council (SAMRC), showed that the Johnson & Johnson booster reduced the risk of hospitalization from COVID-19 among healthcare workers in South Africa after Omicron became the dominant variant...
Source: Johnson and Johnson - December 30, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
RARITAN, N.J., December 29, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of teclistamab for the treatment of patients with relapsed or refractory (R/R) multiple myeloma. Teclistamab is an investigational, off-the-shelf, T-cell redirecting, bispecific antibody targeting both B-cell maturation antigen (BCMA) and CD3.“Despite all the gains that have been made in treating multiple myeloma, the unmet need still remains very high. Our relentless pursuit of treatments ...
Source: Johnson and Johnson - December 29, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20